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	 The	 compound	 N‐(dibenzylcarbamothioyl)‐3‐methylbutanamide	 as	 a	 thiourea	 derivative
was	synthesized	and	structurally	characterized	by	NMR	and	FT‐IR	spectroscopic	techniques.
The	 molecular	 structure	 of	 compound	 was	 also	 characterized	 by	 single	 crystal	 X‐ray
diffraction	 method.	 Crystal	 data	 for	 title	 compound	 C20H24N2OS:	 monoclinic,	 space	 group
C2/c	 (no.	 15),	 a	=	 19.6882(9)	Å,	 b	=	 9.4045(4)	Å,	 c	=	 19.5012(8)	Å,	 β	=	 98.433(2)°,	 V	=
3571.8(3)	Å3,	 Z	=	 8,	 μ(CuKα)	=	 1.665	 mm‐1,	 25057	 reflections	 measured	 (9.168°	 ≤	 2Θ	 ≤
144.196°),	3500	unique	 (Rint	=	0.0322,	Rsigma	=	0.0200)	which	were	used	 in	all	 calculations.
The	 final	R1	 was	 0.0363	 (I>2σ(I))	 and	wR2	 was	 0.0910	 (all	 data).	 Intermolecular	 contacts
obtained	from	X‐ray	single	crystal	diffraction	study	were	also	explored	using	both	Hirshfeld
surfaces	 and	 fingerprint	 plots.	 Hirshfeld	 surface	 analysis	 showed	 the	 occurrence	 of	 S···H,
O···H	and	H···H	contacts	that	display	an	important	role	to	crystal	packing	stabilization	of	the
thiourea	derivative	 compound.	 In	 addition,	 the	 compound	was	 evaluated	 for	 both	 their	 in‐
vitro	antibacterial	and	antifungal	activity.	
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1.	Introduction	
	
Thiourea	 species	 are	 important	 organic	 compounds	 that	
act	 as	 basic	 building	 block	 for	 synthesis	 of	 heterocyclic	
compounds	 [1,2].	 They	 have	 especially	 drawn	 attention	with	
their	wide	range	of	biological	activities,	like	bactericidal,	fungi‐
cidal,	 herbicidal	 and	 insecticidal,	 and	 they	possess	 regulating	
activity	 for	 plant	 growth	 [3‐5].	 They	 also	 have	 potantial	 as	
anti‐cancer	agents	against	various	 leukemia	and	solid	 tumors	
[6].		
N‐(Alkyl/aryl)‐N'‐acylthiourea	 and	 N‐di(alkyl/aryl)‐N´‐
acylthiourea	 derivatives,	 which	 have	 oxygen,	 nitrogen	 and	
sulfur	donor	atoms,	act	as	versatile	ligands	with	various	coor‐
dination	modes.	These	 ligands	exhibit	prevalent	 coordination	
systems	such	as	neutral	bidentate	and	monobasic	bridging	 in	
some	 complexes	 [7‐22].	 Since	 the	 structural	 and	 conforma‐
tional	 properties	 of	 acyl	 thioureas	 has	 been	 recognized,	 the	
use	 of	 transition	 metal	 complexes,	 including	 acylthiourea	
ligands,	 have	 been	 expanded	 in	many	 different	 fields	 [9‐12].	
For	example,	acylthiourea	derivatives	and	their	Co(III)	comp‐
lexes	 have	 shown	 antibacterial	 [13]	 and	 antifungal	 [14]	 acti‐
vities.	 Ni(II)	 complexes,	 containing	 benzoylthiourea	 ligands,	
have	shown	cytotoxicity	against	T47D	cell	[15]	and	according	
to	 the	 investigations	 water	 soluble	 platinum(II)	 benzoyl‐
thiourea	 complexes	 have	 shown	 considerable	 antimalarial	
activity	 [23,24].	Very	 recently,	 there	have	been	many	 studies	
on	noncovalent	interactions	acting	on	the	crystal	structure	and	
packing	of	sulfur‐containing	compounds	[25].	Hydrogen	bonds	
are	generally	dominant	in	the	crystal	packing	of	acyl	thiourea	
compounds,	mostly	determined	to	be	both,	N–H⋯O=C	and	N–
H⋯S=C	 interactions	 [26,27].	When	we	 looked	 at	 the	 synthe‐
sized	 crystals	 before,	 it	 could	 be	 seen	 that	 most	 of	 the	
structures	 displayed	 a	 characteristic	 intermolecular	 pattern	
forming	dimers	by	N–H⋯S	hydrogen	bonding	[7,12].		
The	 success	 of	 many	 applications	 of	 acylthioureas	 are	
based	on	the	formation	of	proper	hydrogen	bonds	with	parti‐
cular	 receptors	 [28,29].	 The	main	 purpose	 of	 our	 study	 is	 to	
understand	 the	 structural	 properties	 of	 thiourea	 derivative	
compounds.	 In	 order	 to	 this	 N‐(dibenzylcarbamothioyl)‐3‐
methylbutanamide	 has	 been	 synthesized	 and	 the	 effect	 of	
intramolecular	 interactions	on	conformational	properties	has	
been	 investigated	 by	 single	 crystal	 X‐ray	 diffraction.	 Inter‐
molecular	 contacts	 obtained	 from	 X‐ray	 single	 crystal	
diffraction	 study	 were	 also	 explored	 using	 both	 Hirshfeld	
surfaces	and	fingerprint	plots.	
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Scheme	1	
	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Infrared	 measurement	 was	 recorded	 in	 the	 range	 400‐
4000	 cm‐1	 on	 a	 Perkin	 Elmer	 Spectrum	 100	 series	 FT‐
IR/FIR/NIR	Spectrometer	Frontier,	ATR	Instrument.	The	NMR	
spectra	were	 recorded	 in	DMSO‐d6	 solvent	on	Bruker	Avance	
III	 400	 MHz	 NaNoBay	 FT‐NMR	 spectrophotometer	 using	
tetramethyl	silane	as	an	internal	standard.		
The	X‐ray	diffraction	data	was	recorded	on	a	Bruker	APEX‐
II	 CCD	 diffractometer.	 A	 suitable	 crystal	 was	 selected	 and	
coated	with	Paratone	oil	and	mounted	onto	a	Nylon	loop	on	a	
Bruker	APEX‐II	CCD	diffractometer.	The	crystal	was	kept	at	T	=	
100	K	 during	 data	 collection.	 The	 data	 were	 collected	 with	
MoKα	 (λ	 =	 0.71073	 Å)	 radiation	 at	 a	 crystal‐to‐detector	
distance	of	40	mm.	Using	Olex2	[30],	the	structure	was	solved	
with	 the	 Superflip	 [31‐33]	 structure	 solution	 program,	 using	
the	Charge	Flipping	solution	method	and	refined	by	full‐matrix	
least‐squares	 techniques	on	F2	using	ShelXL	[34]	with	refine‐
ment	 of	 F2	 against	 all	 reflections.	 Hydrogen	 atoms	 were	
constrained	by	difference	maps	and	were	refined	isotropically,	
and	all	non‐hydrogen	atoms	were	refined	anisotropically.	The	
molecular	 structure	plots	were	prepared	using	PLATON	[33].	
The	geometric	special	details:	all	e.s.d.’s	(except	the	e.s.d.	in	the	
dihedral	angle	between	two	l.s.	planes)	are	estimated	using	the	
full	 covariance	matrix.	The	cell	 e.s.d.’s	 are	 taken	 into	account	
individually	in	the	estimation	of	e.s.d.’s	in	distances,	angles	and	
torsion	angles;	correlations	between	e.s.d.’s	in	cell	parameters	
are	only	used	when	they	are	defined	by	crystal	symmetry.	An	
approximate	 (isotropic)	 treatment	 of	 cell	 e.s.d.’s	 is	 used	 for	
estimating	e.s.d.’s	involving	l.s.	planes.		
	
2.2.	Synthesis	and	characterization	
	
2.2.1.	Synthesis	of	N‐(dibenzylcarbamothioyl)‐3‐methyl	
butanamide		
	
A	 solution	 of	 3‐methylbutanoyl	 chloride	 (5×10‐2	 mol)	 in	
dry	acetone	 (50	mL)	was	added	dropwise	 to	 a	 suspension	of	
potassium	 thiocyanate	 (5×10‐2	mol)	 in	 acetone	 (30	mL).	 The	
reaction	mixture	was	heated	under	reflux	for	30	min,	and	then	
cooled	 to	 room	 temperature.	 A	 solution	 of	 dibenzylamine	
(5×10‐2	mol)	 in	acetone	(10	mL)	was	added	and	the	resulting	
mixture	 was	 stirred	 for	 2	 h.	 After,	 the	 reaction	mixture	was	
poured	 into	 hydrochloric	 acid	 (0.1	 N,	 300	 mL),	 and	 the	
solution	 filtered	 [35].	 The	 solid	 product	 was	 washed	 with	
water	 and	 purified	 by	 recrystallization	 from	 an	 ethanol:	
dichloromethane	mixture	(5:1,	v:v)	(Scheme	1).	FT‐IR	(ATR,	ν,	
cm‐1):	 3272	 (NH),	 3030	 (Ar‐CH),	 1688	 (C=O),	 1589	 (C=C),	
1189	(C=S).	 1H	NMR	(400	MHz,	DMSO‐d6,	ppm):	10.57	(s,	1H,	
NH),	 7.37‐7.14	 (m,	 10H,	Ar‐H),	 5.14	 (s,	 2H,	 CH2),	 4.62	 (s,	 2H,	
CH2),	2.18	(d,	2H,	J	=	8	Hz,	CH2),	2.04	(m,	1H,	CH),	0.88	(d,	6H,	J	
=	 8	 Hz,	 CH3).	 13C	 NMR	 (100	 MHz,	 DMSO‐d6,	 ppm):	 183.46	
(C=S),	164.51	(C=O),	135.79	(Ar‐C),	132.75	(Ar‐C),	132.40	(Ar‐
C),	128.72	(Ar‐C),	128.47	(Ar‐C),	128.39	(Ar‐C),	127.42	(Ar‐C),	
55.56	(C‐N),	54.07	(C‐N),	46.1	(CH2),	27.6	(CH),	22.2	(CH3).	
	
2.3.	Hirshfeld	surfaces	analysis	
	
Analysis	 of	 Hirshfeld	 surfaces	 and	 their	 associated	 two‐
dimensional	 fingerprint	 plots	 of	 the	 title	 compound	 were	
calculated	 using	 CrystalExplorer	 17	 [36].	 The	 Hirshfeld	 sur‐
faces	 mapped	 with	 different	 properties	 dnorm,	 shape	 index,	
curvedness.	The	dnorm	 is	normalized	contact	distance,	defined	
in	terms	of	de,	di	and	the	vdW	radii	of	the	atoms.	Deformation	
density	 is	 generated	 from	 CrystalExplorer	 17,	 over	 the	
electron	density	isosurface	(the	value	is	0.008	e/au3)	using	HF	
method	with	6‐31G(d)	as	basis	set.	
	
2.4.	Antimicrobial	activity	studies	
	
Antimicrobial	 susceptibility	 testing	 was	 performed	 by	
modification	microdilution	of	the	following	literature	methods	
[37,38].	 We	 used	 microbial	 strains	 such	 as	 Staphylococcus	
aureus	(ATCC	25923),	Streptococcus	pneumonia	(ATCC	6303),	
Escherichia	coli	(ATCC	35218),	Pseudomonas	aeruginosa	(ATCC	
27853),	 Acinetobacter	 baumannii	 (RSHM	 2026),	 Candida	
albicans	(ATCC	10231)	and	Candida	glabrata	(RSHM	40199).	
The	 fungal	 and	 bacterial	 cell	 inoculums	 were	 prepared	
from	the	stock	culture	grown	in	Tryptic	Soy	Agar	(TSA)	at	28	
°C	 for	 24	 h	 and	Mueller‐Hinton	 Agar	 (MHA)	 37	 °C	 for	 24	 h,	
respectively.	 The	 microorganism	 suspension	 concentrations	
were	 adjusted	 according	 to	 McFarland	 0.5	 turbidity	 tubes	
using	 sterilized	 saline.	 Stock	 solution	 of	 title	 compound	 was	
prepared	 in	DMSO	 at	 1000	 μg/mL.	 A	modified	microdilution	
test	was	applied	for	antimicrobial	activity	and	the	experiments	
were	 run	 in	 duplicates	 independently.	 For	 antifungal	 activity	
testing,	100	μL	Tryptic	Soy	Broth	(TSB)	was	added	to	each	of	
11	wells.	100	μL	of	chemical	derivative	solution	was	added	to	
the	first	well	and	2‐fold	dilutions	were	prepared.	Then,	5	μL	of	
fungal	suspension	was	added	to	each	tube	except	the	last	one	
which	acted	control	well.		
For	 antibacterial	 activity	 testing,	 100	 μL	 Mueller‐Hinton	
Broth	(MHB)	was	added	to	each	of	11	well.	100	μL	of	chemical	
derivative	solution	was	added	to	the	first	tube	and	2‐fold	dilu‐
tions	 were	 prepared.	 Then,	 5	 μL	 of	 the	 bacterial	 suspension	
was	added	to	each	tube	except	the	last	control	well.	Only	5	μL	
of	 fungal	 and	 bacterial	 suspension	were	 added	 in	 another	 to	
control	tube	without	chemical	and	used	as	control	for	growing.	
All	plate	were	incubated	at	28	°C	(for	fungi)	and	at	37	°C	(for	
bacteria)	for	24	h.	After	the	incubation,	the	minimal	inhibitory	
concentrations	 (MIC)	 were	 noted	 by	 controlling	 the	 growth	
inhibition	for	title	compound.		
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Table	1.	Crystal	data	and	details	of	the	structure	refinement	for	title	compound.	
Parameters	 Compound		
Empirical	formula		 C20H24N2OS	
Formula	weight		 340.47	
Temperature	(K)		 107.18		
Crystal	system		 Monoclinic		
Space	group		 C2/c		
a	(Å)	 19.6882(9)		
b	(Å)	 9.4045(4)	
c	(Å)	 19.5012(8)	
β	(°)		 98.433(2)	
Volume	(Å3)		 3571.8(3)	
Z		 8	
ρcalc	(g/cm3)	 1.266	
μ	(mm‐1)		 1.665	
F(000)		 1456.0		
Crystal	size	(mm3)	 0.42	×	0.36	×	0.24		
Radiation		 CuKα	(λ	=	1.54178)	
2Θ	range	for	data	collection	(°)	 9.168	to	144.196		
Index	ranges		 ‐24	≤	h ≤	20,	‐11	≤	k ≤	11,	‐23	≤	l ≤	24	
Reflections	collected		 25057	
Independent	reflections		 3500	[Rint =	0.0322,	Rsigma =	0.0200]	
Data/restraints/parameters		 3500/0/219	
Goodness‐of‐fit	on	F2		 1.074	
Final	R	indexes	[I≥2σ	(I)]		 R1 =	0.0363,	wR2 =	0.0900	
Final	R	indexes	[all	data]		 R1	=	0.0377,	wR2	=	0.0910		
Largest	diff.	peak/hole	(e	Å‐3)	 0.58/‐0.64	
	
	
	
Figure	1.	Molecular	structure	of	the	title	compound	showing	the	atom‐numbering	scheme	
	
	
	
Fluconazole	and	ampicillin	were	used	as	 reference	drugs.	
The	 results	 were	 read	 visually	 and	 by	 measuring	 optical	
density	for	24	h.	
	
3.	Result	and	discussion	
	
3.1.	Spectral	characterization	
	
The	 title	 compound	 was	 synthesized	 according	 to	 the	
general	 method	 early	 reported	 by	 Douglass	 and	 Dains	 [35].	
The	synthesis	procedure	of	the	title	compound	involves	the	in	
situ	 reaction	 between	 3‐methylbutanoyl	 chloride	 and	 KSCN	
and	the	reaction	of	the	intermediate	3‐methylbutanoyl	isothio‐
cyanate	 with	 dibenzylamine.	 The	 reaction	 proceeds	 via	 a	
nucleophilic	 addition	of	 the	amine	 to	 the	 isothiocyanate	with	
good	 yields.	 The	 synthesized	 compound	 was	 purified	 by	
recrystallization	 from	 an	 dichloromethane:ethanol	 mixture	
and	 characterized	 by	 1H	 NMR,	 13C	 NMR	 and	 FT‐IR	 spectros‐
copy.	
The	title	compound	1	shows	characteristic	peaks	in	FT‐IR	
due	to	ν(N‐H)	and	ν(C=O)	groups	stretching	vibration	at	3272	
and	 1688	 cm‐1,	 respectively.	 Also,	 the	 band	 at	 3030	 cm‐1	
corresponds	 to	 stretching	 of	 ν(Csp2‐H)	 groups	 of	 the	 title	
compound.	Intense	absorptions	in	the	1500‐1600	cm–1	region	
due	to	the	δ(N‐H)	deformation	modes	are	usually	observed	in	
the	infrared	spectra	of	thioureas	[39].	
In	1H	NMR,	 the	title	exhibited	broad	signal	at	 the	δ	10.98	
ppm	which	was	assigned	to	the	N‐H	proton.	The	signals	for	the	
aromatic	 protons	 in	 the	 compound	 1	 were	 observed	 in	 the	
range	of	δ	7.49‐7.31	ppm.	Also,	the	peak	at	δ	2.40	ppm	seen	as	
multiplet	 in	1H	NMR	spectrum	correspond	 to	CH	group	while	
the	 peak	 at	 δ	 0.98	 ppm	 seen	 as	 triplet	 correspond	 to	 CH3	
groups.	13C	NMR	spectrum	showed	the	peaks	at	about	δ	183.46	
for	C=S	and	164.51	ppm	for	C=O,	respectively.		
	
3.2.	Crystal	structure	analysis	
	
Good	 quality	 single	 crystals	 were	 obtained	 by	 slow	
evaporation	 of	 a	 dichloromethane:ethanol	 (1:5,	 v:v)	 solution.	
The	crystal	belongs	to	the	monoclinic	system	with	space	group	
C2/c.	 The	 crystal	 data	 and	 structure	 refinement	 parameters	
are	 summarized	 in	 Table	 1.	 Selected	 bond	 lengths	 and	 bond	
angles	 are	 given	 in	 Table	 2.	 The	 asymmetric	 unit	 of	 the	 title	
complex	 along	with	 an	 atom	numbering	 scheme	 is	 shown	 in	
Figure	1.	
The	C=S	and	C=O	bonds	show	a	 typical	double	bond	cha‐
racter	with	bond	lengths	of	1.674	Å	and	1.225	Å,	respectively	
[40‐46].	 The	 C‐N	 bond	 lengths	 for	 the	 title	 compound	 are	
shorter	 than	a	C‐N	 single	bond.	This	 fact	 indicates	 that	 these	
bonds	 have	 a	 pronounced	 double	 bond	 character.	 In	 the	
compound,	O=C‐N‐C	 the	torsion	angle	 is	at	 the	of	20.15°.	The	
dihedral	 angles	 between	 the	 O‐C‐N	 and	 S‐C‐N	 planes	 of	
compound	is	50.15°.	
The	molecular	structure	of	title	compound	is	stabilized	by	
C‐H···S	(2.543	Å,		114	°)	intramolecular	hydrogen	bonds	(Table	
3).		
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Table	2.	Selected	bond	lengths	(Å),	bond	and	torsion	angles	(°)	of	title	compound.	
Atom	 Length	(Å)	 Atom	 Angle	(°)	 Atom	 Angle	(°)	
S1	 C2	 1.6737(14)	 C1	 N1	 C2 123.67(11) O1 C1 C3 C4	 67.75(16)
O1	 C1	 1.2246(17)	 C2	 N2	 C7 124.54(11) N1 C1 C3 C4	 ‐109.27(13)
N1	 C1	 1.3829(17)	 C2	 N2	 C14 120.75(11) N2 C7 C8 C9	 119.10(14)
N1	 C2	 1.4150(17)	 C14	 N2	 C7 114.70(10) N2 C7 C8 C13	 ‐61.36(16)
N2	 C2	 1.3383(17)	 O1	 C1	 N1	 122.95(12)	 N2	 C14	 C15	 C16	 ‐50.04(17)	
N2	 C7	 1.4785(17)	 O1	 C1	 C3	 121.85(12)	 N2	 C14	 C15	 C20	 133.69(13)	
N2	 C14	 1.4708(16)	 N1	 C1	 C3 115.14(11) C1 N1 C2 S1	 ‐120.17(12)
C1	 C3	 1.5060(18)	 N1	 C2	 S1	 117.65(10)	 C1	 N1	 C2	 N2	 60.12(17)	
	
Table	3.	Intra‐	and	inter‐molecular	hydrogen	bonds	for	title	compound	(Å,	°).	
D‐H···A	 d(D‐H)	 d(H···A)	 d(D···A)	 	(D‐H···A	)		 Symmetry	
C14‐H14⋅⋅⋅S1	 0.99	 2.543	 3.0763(5)	 114	 ‐	
N1‐H1⋅⋅⋅O1	 0.88	 2.26	 3.0441(14)	 148.7	 1/2‐x,	1/2+y,	1/2‐z	
C3‐H3A⋅⋅⋅O1	 0.99	 2.40	 3.3093(16) 152.0 1/2‐x,	1/2+y,	1/2‐z	
C3‐H3A⋅⋅⋅S1	 0.99	 2.84	 3.7369(13) 151.5 1/2‐x,	‐1/2+y,1/2‐z	
	
	
(a)	 (b)
	
Figure	2.	(a)	The	intermolecular	N‐H⋯O,	C‐H⋯O	and	C‐H⋯S	hydrogen	bonds,	(b)	The	C‐H···π	stacking	interactions	formed	along	the	a‐axis.	
	
The	crystal	structure	of	 title	compound	 is	also	dominated	
by	intermolecular	hydrogen	bonds	such	as	N‐H···O,	C‐H···O,	C‐
H···S	 that	 cause	 to	 form	molecular	pack	 (Figure	2a,	 Table	3).	
The	H···O	intermolecular	interactions	are	generated	by	amide	
and	CH2	hydrogen	atoms	and	the	carbonyl	group	oxygen	atom	
function	as	hydrogen	bond	acceptors,	 forcing	the	molecule	 to	
form	 two	 hydrogen	 bonds.	 Due	 to	 this,	 the	 molecule	 forms	
parallel	chain	to	the	a‐axis.	Similarly,	the	H···S	 intermolecular	
interactions	 occur	 between	 thiocarbonyl	 sulphur	 atom	 and	
CH2	hydrogen	atoms.	So,	molecules	zig‐zag	chains	along	the	a‐
axis	 inter‐connected	via	 the	S···H	 contacts.	The	 crystal	 lattice	
of	 the	 title	 compound	 is	 additionally	 supported	 by	 C–H···π	
interactions	 (2.991	 Å,	 symmetry	 code:	 3/2‐x,	 ‐1/2+y,	 3/2‐z)	
formed	bet‐ween	methyl	groups	and	phenyl	rings	of	dibenzyl	
amine	part	along	the	same	axis	(Figure	2b).	
The	sight	of	the	crystal	packing	along	the	b‐axis	in	the	title	
compound	reveals	π···π	interactions.	In	the	crystal	structure	of	
the	 title	 compound,	 Cg(1)	 and	Cg(2)	 are	 the	 centroids	 of	 the	
rings	C8‐C13	and	C15‐C20,	respectively.	Two	adjacent	molecu‐
les	 are	 connected	 together	by	 the	π⋯π	stacking	between	 the	
dibenzylamine	 rings	 with	 Cg(1)···Cg(2)	 distance	 of	 4.736	 Å	
with	symmetry	code:	1‐x,	1‐y,	1‐z	and	4.322	Å	with	symmetry	
code:	1‐x,	y,	3/2‐z.	These	 interactions	 infinitely	repeated	 lead	
to	 a	 ladder‐like	 chain	 running	 along	 b‐direction	 (Figure	 3,	
Table	4).		
The	presence	of	intermolecular	hydrogen	bonds,	π···π	and	
C–H···π	stacking	interactions	in	the	title	compound	contribute	
to	 stabilize	 the	 crystal	 packing	 and	 account	 for	 the	 ease	 of	
obtaining	 single	 crystals	 for	 this	 compound,	 because	 it	 is	 a	
relatively	strong	bond	type	and	thus	has	great	influence	on	the	
supramolecular	arrangement.	
	
3.3.	Hirshfeld	surfaces	analysis	
	
Intermolecular	contacts	obtained	from	X‐ray	single	crystal	
diffraction	 study	 were	 also	 explored	 using	 both	 Hirshfeld	
surfaces	 and	 fingerprint	 plots.	 Therefore,	 the	 intermolecular	
interactions	in	the	crystal	structure	of	the	title	compound	have	
been	 examined	via	 Hirshfeld	 surface	 analysis	 and	 fingerprint	
plots.		
The	 Hirshfeld	 surfaces	 of	 the	 title	 compound	 have	 been	
mapped	 over	 a	 dnorm	 and	 shape	 index	 functions.	 All	 the	
Hirshfeld	 surfaces	 are	 shown	 as	 transparent	 to	 allow	 visua‐
lization	 of	 the	 title	 compound,	 around	 which	 they	 were	
calculated.	 Red‐blue‐white	 color	 scheme	 seen	 in	 the	 dnorm	
surface	 represent	shorter	 contacts,	 longer	contacts	 and	equal	
contacts	 around	 the	 Van	 der	 Walls	 separation,	 respectively	
[47].		
As	 can	 be	 seen	 in	 the	 Hirshfeld	 surfaces	 of	 the	 title	
compound,	the	most	intense	red	regions	occur	near	to	C=O,	N–
H	and	CH2	groups,	due	to	N–H···O	and	C‐H···O	hydrogen	bonds	
present	in	structure.	Also,	the	weaker	H···S=C	contacts	formed	
between	C=S	and	CH2	groups	in	the	Hirshfeld	surface	mapped	
over	 dnorm	 give	 rise	 to	 visible	 as	 weak	 red	 spots.	 Figure	 4	
displays	the	Hirshfeld	surface	of	title	compound	mapped	over	
dnorm	 in	 front	 and	 back	 views	 and	 dnorm	 Hirshfeld	 surface	
surrounded	 by	 one	 neighboring	 molecule	 associated	 with	
close	contacts.	When	we	 look	at	Hirshfeld	 surface	of	 the	 title	
compound,	 it	 is	 observed	 that	 except	 the	 H···O	 and	 H···S	
interactions,	 is	 not	 involved	 in	 any	 close	 intermolecular	
contact,	 resulting	 in	 a	 white‐to‐blue	 gradient	 color	 in	 the	
Hirshfeld	surface.	
The	analysis	about	C···H	interactions	of	the	title	compound	
was	done	using	 the	Hirshfeld	surface	shape	 index	 (Figure	5).	
C···H/H···C	 interactions	 are	mainly	 responsible	 for	 the	mole‐
cular	 packing	 in	 the	 supramolecular	 structure	 and	 represent	
C‐H···π	 interactions.	 These	 interactions	 on	 the	 Hirshfeld	
surface	 mapped	 with	 shape	 index	 function	 are	 appearing	 as	
hollow	orange	areas	(π···H‐C)	and	bulging	blue	areas	(C‐H···π).	
The	 2D	 fingerprint	 plots	 obtained	 from	 the	 Hirshfeld	
surface	 analysis	 illustrate	 the	 percentage	 contributions	 of	
intermolecular	 interactions	 on	 the	 molecules	 [48,49].	 2D	
fingerprint	plots	are	mainly	responsible	for	crystal	packing	of	
solid	networks	of	the	compound.		
414	 Gumus	et	al.	/	European	Journal	of	Chemistry	8	(4)	(2017)	410‐416	
	
	
Table	4.	Geometrical	parameters	of	π⋯π	interactions	for	title	compound	(Å,	°).	
Rings	I–J	a	 Cg(I)⋅⋅⋅Cg(J)	b	 γ	c	 Cg(I)‐perp	d	 Cg(J)‐perp	e	 Symmetry	
Cg(1)⋅⋅⋅Cg(2)		 4.7359(8)		 49.4 ‐3.0845(5)	 ‐3.6763(5)	 1‐x,	1‐y,	1‐z		
Cg(2)⋅⋅⋅Cg(1)	 5.7814(8)	 64.5 2.4883(5) ‐3.1475(5)	 x,	y,	z		
Cg(2)⋅⋅⋅Cg(1)	 4.7359(8)		 39.1	 ‐3.6762(5)		 ‐3.0845(5)		 1‐x,	1‐y,	1‐z		
Cg(2)⋅⋅⋅Cg(2)	 4.3217(8)		 35.4		 3.5211(5)		 3.5211(5)		 1‐x,	y,	3/2‐z		
a	Cg(1)	and	Cg(2)	are	the	centroids	of	the	rings	C8‐C13	and	C15–C20	for	the	title	compound,	respectively.	
b	Centroid	distance	between	ring	I	and	ring	J.	
c	Angle	between	the	centroid	vector	Cg(I)⋯Cg(J)	and	the	normal	to	plane	J.	
d	Perpendicular	distance	of	Cg(I)	on	ring	J	(Å).	
e	Perpendicular	distance	of	Cg(J)	on	ring	I	(Å).	
	
	
	
Figure	3.	The	intermolecular	π···π	stacking	interactions	form	infinitely	repeated	a	ladder‐like	chain	running	along	b‐direction.	
	
	
	 	
	
Figure	4.	The	Hirshfeld	surface	of	the	title	compound	mapped	over	dnorm (front	and	back)	and	dnorm Hirshfeld	surface surrounded	by	one	neighboring	molecule	
associated	with	close	contacts.	
	
	
Moreover,	 these	 plots	 can	 be	 decomposed	 to	 quantify	
particular	 contributions	 of	 intermolecular	 interactions	 in	 the	
molecular	 packing	 of	 a	 solid	 network.	 Also,	 the	 fingerprint	
plots	 indicate	a	molecule	act	as	a	donor	(de	>	di)	and	another	
one	 is	 found	as	an	acceptor	 (de	<	di).	 This	analysis	 show	 that	
the	contributions	to	the	total	Hirshfeld	surface	of	H⋅⋅⋅H,	C⋅⋅⋅H,	
O⋅⋅⋅H	and	S⋅⋅⋅H	including	reciprocal	contacts	for	the	title	com‐
pound	 is	 observed	 as	 64.0,	 19.1,	 4.9	 and	 10.0%,	 respectively	
(Figure	6).	
The	 3D	 electrostatic	 potential	 and	 deformation	 density	
maps	 of	 the	 title	 compound	 were	 generated	 from	 the	
CrystalExplorer	 17	 [36],	 (isosurface	 0.05	 au	 for	 electrostatic	
potential	 and	 isosurface	 0.008	 au	 for	 deformation	 density)	
using	HF	method	with	6‐31G(d)	as	basis	set.		
Figure	 7a	 displays	 the	 isosurface	 representation	 electro‐
static	potential	surface	of	the	title	compound.	The	electrostatic	
potential	 map	 shows	 that	 a	 large	 electropositive	 region	 is	
around	 the	 dibenzylamine	 rings	 and	 a	 large	 electronegative	
region	 is	 at	 the	 vicinity	 of	 the	 thiocarbonyl	 and	 on	 carbonyl	
oxygen	 atom.	 The	 positive	 electrostatic	 potential	 surface	
(blue)	 around	 the	 dibenzylamine	 ring	 occurs	 because	 of	 the	
positive	charge	contribution	of	C	atoms	of	the	ring.		
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Table	5.	MIC	values	(μg/mL)	of	the	title	compound	tested	against	the	Gram	positive,	Gram	negative	bacteria	and	fungal.		
Compound	 Gram	positive	bacteria	 Gram	negative	bacteria	 Fungi	
S.		
Aureus	
S.		
Pneumoniae	
B.	
Subtilis	
E.	
Coli	
P.	
Aeruginosa	
A.	
Baumannii	
C.		
Albicans	
C.	
Glabrata	
Title	compound	 62.5	 62.5	 62.5	 62.5	 62.5	 31.25	 31.25	 31.25	
Flucanozole	 	 	 *	 *
Ampicillin	 *	 *	 * 31.25 * 15.62 	 	
“*”:	Effective	in	all	concentrations	used.	
	
	
	
Figure	5.	The	Hirshfeld	surface	mapped	over	the	shape	index	with	C‐H···π interactions	between	two vicinal molecules	of	title	compound.
	
	
	
Figure	6.	2D	fingerprint	plots	for	interactions	present	in	the	title	compound.	
	
	
	
	
	
	
	
	
(a)	 (b)	
	
Figure	 7.	 (a)	 Electrostatic	 potential	 mapped	 on	 Hirshfeld	 surface	 (different	 orientation)	 with	 0.05	 au.	 Blue	 region	 corresponds	 to	 positive	 electrostatic	
potential	and	red	region	to	negative	electrostatic	potential,	(b)	3D‐deformation	density	map	of	the	title	compound	with	0.008	au.	
	
	
The	 O1	 atom	 also	 exhibits	 a	 high	 negative	 electrostatic	
potential	region.	This	atom	forms	hydrogen‐bonding	interact‐
tions	with	the	NH	and	CH2	groups	of	the	title	compound.	
A	 3D‐deformation	 density	 map	 showing	 the	 presence	 of	
CD	 regions	 (in	 red)	 and	 CC	 regions	 (in	 blue)	 on	 the	 title	
compound,	 is	 also	 mapped	 by	 CrystalExplorer	 17	 [36].	 The	
deformation	density	 represents	differences	between	 the	 total	
electron	 density	 of	 a	 molecule	 and	 the	 electron	 density	 of	
“neutral	 spherical	 unperturbed	 atoms”	 superimposed	 in	 the	
same	 of	 the	 molecule	 [50,51].	 The	 electrostatic	 deformation	
density	map	reveals	the	presence	of	a	charge	depletion	region	
(in	 red)	 at	 the	 hydrogen	 atoms	 (hydrogen	 atoms	 H1/H14	 of	
NH	 and	 CH2	 groups)	 which	 is	 directed	 towards	 the	 charge	
concentration	 region	 (in	 blue)	 over	 oxygen	 atom,	 facilitating	
formation	of	the	H···O	contacts	in	the	crystal.	In	Figure	7b,	the	
green	dashed	 line	 indicates	 the	 intramolecular	H···O	 interact‐
tion.	The	charge	depletion	and	charge	concentration	regions	in	
the	H···O	 contact	provide	 the	overall	 stabilization	 in	 complex	
structure.	
	
3.4.	Antimicrobial	activity	studies	
	
The	 in	 vitro	biological	 activity	 of	 the	 title	 compound	was	
tested	 towards	 six	 Gram	 positive/negative	 bacteria	 and	 two	
types	 of	 fungal.	 The	 organisms	 used	 in	 the	 present	
investigations	included	S.	Aureus,	B.	Subtilis	and	S.	pneumoniae	
(as	 Gram	 positive	 bacteria),	 E.	 coli,	 P.	 aeruginosa	 and	 A.	
baumannii	 (as	Gram	negative	bacteria)	and	C.	albicans	and	C.	
glabrata	(as	fungal).	The	results	of	the	biological	activity	of	the	
title	compound	are	compared	with	fluconazole	(for	fungal)	and	
ampicillin	 (for	 bacteria)	 reference	 drugs.	 The	 obtained	 MIC	
values	are	listed	in	Table	5.	
According	 to	 data	 generated	 from	 this	 study,	 the	 title	
compound	showed	moderate	inhibitory	action	against	bacteria	
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strains	 with	 MIC	 values	 ranging	 between	 31.25‐62.5	 μg/mL	
and	 exhibited	 the	 highest	 activities	 against	 A.	 baumannii	
bacterium	with	MIC	values	at	31.25	μg/mL.	But	when	the	title	
compound	was	 compared	 with	 ampicillin	 used	 as	 reference	
drug,	 it	 demonstrated	 lower	 activity	 against	 all	 the	 bacteria	
chains.	 The	 title	 compound	 inhibited	 the	 growth	 of	 fungal	
strains	with	MIC	values	at	31.25	μg/mL	but	it	isn’t	as	effective	
as	fluconazole	used	as	reference	drug	against	all	fungal	strains.	
Hence,	 from	all	 these	observations,	 it	was	concluded	 that	 the	
title	compound	could	not	be	exploited	for	the	design	of	novel	
antimicrobial	drug.	
	
4.	Conclusion	
	
In	 this	 study,	 N‐(dibenzylcarbamothioyl)‐3‐methylbutan‐
amide	 as	 a	 thiourea	 derivative	 was	 synthesized	 and	
structurally	 characterized	 by	 NMR	 and	 FT‐IR	 spectroscopic	
techniques.	 The	 molecular	 structure	 of	 the	 prepared	 com‐
pound	 was	 also	 characterized	 by	 the	 single	 crystal	 X‐ray	
diffraction	method.	 In	 the	 title	 compound,	 the	 intermolecular	
contacts	 have	 been	 also	 examined	 based	 on	 the	 Hirshfeld	
surfaces	 and	 their	 associated	 2D	 fingerprint	 plots.	 Further‐
more,	the	title	compound	was	evaluated	for	both,	their	in‐vitro	
antibacterial	and	antifungal	activity.	
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